Tonix Pharmaceuticals Holding Corp.

Antibody-drug conjugate (ADC) developer Adcendo has been busy during the last year and a half since the company raised a €31m ($32.3m) extension of the €51m ($53.2m) series A it originally raised in 2

Two of the most formative experiences I gained working as the commercial person within pharmaceutical development teams involved the inability to predict either the absence of patients or the absence

The declaration of mpox as a public health emergency of international concern is seeing a handful of small companies benefit from urgent demand for vaccine supplies, and Tonix Pharmaceuticals is the

The recent partial success of Vertex Pharmaceuticals Incorporated ’s non-opioid product VX-548 in a pair of acute pain studies positions the product as potentially the first new non-opioid analgesic